Home › Targets › TGF-β

TGF-β (2 companies · 5 programs)

Companies with an active program directed at TGF-β.

Bicara Therapeutics Inc. BCAX

ficerafusp alfa — Head and Neck Squamous Cell Carcinoma Phase 2
ficerafusp alfa — Colorectal Cancer Phase 1
ficerafusp alfa — Cutaneous Squamous Cell Carcinoma Phase 1
ficerafusp alfa — Anal Squamous Cell Carcinoma Phase 1

Cue Biopharma, Inc. CUE

CUE-401 Preclinical